Compass Therapeutics, Inc. (CMPX)

NASDAQ: CMPX · IEX Real-Time Price · USD

1.700

+0.050 (3.03%)

At close: May 3, 2024, 4:00 PM

1.770

+0.070 (4.12%)

Pre-market: May 6, 2024, 7:23 AM EDT

Compass Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	24.23	34.95	144.51	47.34	25.57
Short-Term Investments	128.23	151.66	0	0	0
Cash & Cash Equivalents	152.46	186.61	144.51	47.34	25.57
Cash Growth	-18.30%	29.13%	205.27%	85.16%	-
Other Current Assets	1.42	8.18	2.59	2.86	0.67
Total Current Assets	153.88	194.79	147.11	50.2	26.24
Property, Plant & Equipment	2.67	4.53	6.33	1.13	3.75
Other Long-Term Assets	0.32	0.32	0.32	0.58	0.39
Total Long-Term Assets	2.99	4.85	6.65	1.71	4.14
Total Assets	156.88	199.65	153.76	51.91	30.38
Accounts Payable	4.09	3.38	0.87	1.06	0.63
Current Debt	1.2	1.1	0.99	7.47	5.58
Other Current Liabilities	2.51	11.69	8.78	1.57	3.62
Total Current Liabilities	7.8	16.17	10.63	10.1	9.82
Long-Term Debt	0.54	1.84	3.05	1.87	9.29
Total Long-Term Liabilities	0.54	1.84	3.05	1.87	9.29
Total Liabilities	8.34	18.01	13.68	11.97	19.11
Total Debt	1.73	2.94	4.04	9.33	14.87
Debt Growth	-40.95%	-27.30%	-56.75%	-37.23%	-
Retained Earnings	-315.31	-272.81	-233.59	-151.41	-121.91
Comprehensive Income	0.04	-0.3	0	0	0
Shareholders' Equity	148.54	181.64	140.08	39.95	-118.6
Net Cash / Debt	150.73	183.67	140.48	38.01	10.7
Net Cash / Debt Growth	-17.94%	30.75%	269.63%	255.29%	-
Net Cash Per Share	1.19	1.75	2.23	1.23	1.60
Working Capital	146.08	178.62	136.47	40.1	16.42
Book Value Per Share	1.17	1.73	2.23	1.30	-17.73

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).